Approval · Notice of Compliance 26005 · 2021
AZILECT: Notice of Compliance 26005
Issued June 3, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26005
- Date
- June 3, 2021
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
Medicinal ingredients
- RASAGILINE MESYLATE 0.5 MG per TAB
- RASAGILINE MESYLATE 1 MG per TAB